Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) shot up 2.5% on Wednesday after Needham & Company LLC raised their price target on the stock from $315.00 to $400.00. Needham & Company LLC currently has a buy rating on the stock. Axon Enterprise traded as high as $320.00 and last traded at $319.13. 143,084 shares were traded during mid-day trading, a decline of 69% from the average session volume of 456,035 shares. The stock had previously closed at $311.27.
A number of other brokerages have also recently weighed in on AXON. JMP Securities raised their price target on Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 6th. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Argus began coverage on Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price target for the company. The Goldman Sachs Group raised their price target on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Finally, StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $309.45.
Read Our Latest Analysis on AXON
Institutional Trading of Axon Enterprise
Large investors have recently made changes to their positions in the stock. American Century Companies Inc. boosted its stake in Axon Enterprise by 103.8% in the 1st quarter. American Century Companies Inc. now owns 6,194 shares of the biotechnology company’s stock worth $853,000 after buying an additional 3,155 shares during the last quarter. Private Advisor Group LLC boosted its stake in Axon Enterprise by 40.3% in the 1st quarter. Private Advisor Group LLC now owns 3,458 shares of the biotechnology company’s stock worth $476,000 after buying an additional 994 shares during the last quarter. Great West Life Assurance Co. Can boosted its stake in Axon Enterprise by 12.3% in the 1st quarter. Great West Life Assurance Co. Can now owns 37,062 shares of the biotechnology company’s stock worth $5,247,000 after buying an additional 4,048 shares during the last quarter. Raymond James Trust N.A. boosted its stake in Axon Enterprise by 4.7% in the 1st quarter. Raymond James Trust N.A. now owns 3,753 shares of the biotechnology company’s stock worth $517,000 after buying an additional 168 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Axon Enterprise by 2.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 236,287 shares of the biotechnology company’s stock worth $32,545,000 after buying an additional 4,897 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Axon Enterprise Trading Up 2.2 %
The business has a 50 day simple moving average of $294.92 and a 200-day simple moving average of $253.06. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $24.02 billion, a price-to-earnings ratio of 138.37 and a beta of 0.93.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. On average, equities analysts predict that Axon Enterprise, Inc. will post 2.43 earnings per share for the current year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
